ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07755
0,05%
Bitcoin
60.929,05
-0,85%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Eagle Capital Growth Fund Inc (GRF)

  7. Eagle Capital Growth Fund Inc (GRF) News

GRF

Eagle Capital Growth (GRF)

Eagle Capital Growth Fund Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:GRF
DatumZeitQuelleÜberschriftSymbolFirma
18/04/202415h30GlobeNewswire Inc.Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.AMEX:GRFEagle Capital Growth Fund Inc
04/04/202410h00GlobeNewswire Inc.Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus ScreeningAMEX:GRFEagle Capital Growth Fund Inc
07/03/202417h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:GRFEagle Capital Growth Fund Inc
06/03/202418h56Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportAMEX:GRFEagle Capital Growth Fund Inc
28/02/202417h20Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
23/02/202422h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
23/02/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202409h16GlobeNewswire Inc.Grifols announces positive topline phase 3 fibrinogen clinical trial resultsAMEX:GRFEagle Capital Growth Fund Inc
13/02/202421h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
13/02/202421h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
13/02/202421h09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
27/12/202321h58Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]AMEX:GRFEagle Capital Growth Fund Inc
15/11/202314h00GlobeNewswire Inc.Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin DeficiencyAMEX:GRFEagle Capital Growth Fund Inc
07/11/202322h45Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
06/11/202314h00GlobeNewswire Inc.GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023AMEX:GRFEagle Capital Growth Fund Inc
25/10/202300h30GlobeNewswire Inc.Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTADAMEX:GRFEagle Capital Growth Fund Inc
13/10/202323h30Business WireEagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in CashAMEX:GRFEagle Capital Growth Fund Inc
02/10/202320h30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:GRFEagle Capital Growth Fund Inc
02/10/202320h16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:GRFEagle Capital Growth Fund Inc
30/08/202321h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
30/08/202321h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
15/08/202323h30Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
15/08/202321h45Edgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualAMEX:GRFEagle Capital Growth Fund Inc
01/08/202314h00GlobeNewswire Inc.Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and AnalyticsAMEX:GRFEagle Capital Growth Fund Inc
12/05/202319h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:GRFEagle Capital Growth Fund Inc
12/05/202318h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:GRFEagle Capital Growth Fund Inc
19/04/202321h25Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)AMEX:GRFEagle Capital Growth Fund Inc
18/04/202316h30PR Newswire (US)Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023AMEX:GRFEagle Capital Growth Fund Inc
17/03/202314h40Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)AMEX:GRFEagle Capital Growth Fund Inc
01/03/202312h42Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)AMEX:GRFEagle Capital Growth Fund Inc
 Showing the most relevant articles for your search:AMEX:GRF

Kürzlich von Ihnen besucht

TG
NOV
Novo Nordisk
TG
D7G
Nel ASA
COIN
SOLUSD
Solana
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
FX
EURGBP
Euro vs Sterling
CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
TG
BAS
BASF
CCOM
SILVER
SILVER
CCOM
US30
US 30
NYSE
NKE
Nike
TG
DBK
Deutsche Bank
PM
XAUUSD
Gold vs US Dollar
DBI
MDAX
MDAX
FX
EURJPY
Euro vs Yen
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten